APA (7th ed.) Citation

Elborn, J., Horsley, A., MacGregor, G., Bilton, D., Grosswald, R., Ahuja, S., & Springman, E. (2017). Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis. CTS: Clinical & Translational Science, 10(1), 28. https://doi.org/10.1111/cts.12428

Chicago Style (17th ed.) Citation

Elborn, JS, A. Horsley, G. MacGregor, D. Bilton, R. Grosswald, S. Ahuja, and EB Springman. "Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis." CTS: Clinical & Translational Science 10, no. 1 (2017): 28. https://doi.org/10.1111/cts.12428.

MLA (9th ed.) Citation

Elborn, JS, et al. "Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis." CTS: Clinical & Translational Science, vol. 10, no. 1, 2017, p. 28, https://doi.org/10.1111/cts.12428.